Atrial fibrillation burden: a new outcome predictor and therapeutic target

被引:18
|
作者
Becher, Nina [1 ,2 ]
Metzner, Andreas [1 ,2 ]
Toennis, Tobias [1 ,2 ]
Kirchhof, Paulus [1 ,2 ,3 ]
Schnabel, Renate B. [1 ,2 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Martinistr 52, D-20246 Hamburg, Germany
[2] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Luebeck, Postdamer Str 58, D-10785 Berlin, Germany
[3] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, England
关键词
Atrial fibrillation; Burden; Oral anticoagulation; Stroke; Rhythm control; QUALITY-OF-LIFE; CATHETER ABLATION; FOLLOW-UP; RHYTHM CONTROL; RADIOFREQUENCY ABLATION; TERM PROGRESSION; ISCHEMIC-STROKE; MEDICAL THERAPY; HEART-FAILURE; RISK;
D O I
10.1093/eurheartj/ehae373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is not a dichotomous disease trait. Technological innovations enable long-term rhythm monitoring in many patients and can estimate AF burden. These technologies are already used to detect and monitor AF. This review describes the relation between AF burden and outcomes and potential effects of AF burden reduction. A lower AF burden is associated with a lower risk of stroke and heart failure in patients with AF: stroke risk without anticoagulation is lower in patients with device-detected AF and a low AF burden (stroke rate 1%/year) than in patients with persistent and permanent AF (stroke rate 3%/year). Paroxysmal AF shows intermediate stroke rates (2%/year). Atrial fibrillation burden-reducing interventions can reduce cardiovascular outcomes in patients with AF: early rhythm control reduces cardiovascular events including stroke and heart failure in patients with recently diagnosed AF and cardiovascular conditions. In patients with heart failure and AF, early rhythm control and AF ablation, interventions that reduce AF burden, reduce mortality and heart failure events. Recent technological innovations allow to estimate AF burden in clinical care, creating opportunities and challenges. While evidence remains limited, the existing data already suggest that AF burden reduction could be a therapeutic goal. In addition to anticoagulation and treatment of cardiovascular conditions, AF burden reduction emerges as a therapeutic goal. Future research will define the AF burden that constitutes a relevant risk of stroke and heart failure. Technologies quantifying AF burden need careful validation to advance the field. Graphical Abstract Clinical classification of atrial fibrillation (AF) and quantitative classification of AF using AF burden and its interaction and influence on outcomes, precision therapy, and clinical trials and research.
引用
收藏
页码:2824 / 2838
页数:15
相关论文
共 50 条
  • [41] BIRC3 AS A PREDICTOR OF OUTCOME AND A NEW THERAPEUTIC TARGET IN TMZ RESISTANT GLIOBLASTOMA TUMORS
    Morelli, Mariangela
    Franceschi, Sara
    Lessi, Francesca
    Aretini, Paolo
    Pastore, Aldo
    Corradi, Elena
    Marranci, Andrea
    Gambacciani, Carlo
    Pieri, Francesco
    Grimod, Gianluca
    Montemurro, Nicola
    Giacomarra, Manuel
    Menicagli, Michele
    Ferri, Gianmarco
    Pasqualetti, Francesco
    Sanson, Marc
    Picca, Alberto
    Di Stefano, Anna Luisa
    Santonocito, Orazio Santo
    Mazzanti, Chiara Maria
    NEURO-ONCOLOGY, 2023, 25
  • [42] BIRC3 AS A PREDICTOR OF OUTCOME AND A NEW THERAPEUTIC TARGET IN TMZ RESISTANT GLIOBLASTOMA TUMORS
    Morelli, M.
    Franceschi, S.
    Lessi, F.
    Aretini, P.
    Pastore, A.
    Corradi, E.
    Marranci, A.
    Menicagli, M.
    Giacomarra, M.
    Ferri, G.
    Pasqualetti, F.
    Sanson, M.
    Picca, A.
    Santonocito, O. S.
    Di Stefano, A.
    Mazzanti, C.
    NEURO-ONCOLOGY, 2023, 25 : 64 - 64
  • [43] Atrial defibrillation threshold as a novel predictor of clinical outcome of catheter ablation for persistent atrial fibrillation
    Komatsu, Yuki
    Uno, Kikuya
    Otomo, Kiyoshi
    Nagata, Yasutoshi
    Taniguchi, Hiroshi
    Ogura, Kazuyoshi
    Egami, Yasuyuki
    Takayama, Kei
    Kakita, Ken
    Iesaka, Yoshito
    EUROPACE, 2011, 13 (02): : 213 - 220
  • [44] Liver Disease as a Predictor of New-Onset Atrial Fibrillation
    Huang, William A.
    Dunipace, Eric A.
    Sorg, Julie M.
    Vaseghi, Marmar
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (15):
  • [45] Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China New Insights Into the Global Burden of Atrial Fibrillation
    Guo, Yutao
    Tian, Yingchun
    Wang, Hao
    Si, Quanjin
    Wang, Yutang
    Lip, Gregory Y. H.
    CHEST, 2015, 147 (01) : 109 - 119
  • [46] Atrial gradient as a potential predictor of atrial fibrillation
    Chandra, P
    Rosen, TS
    Herweg, B
    Plotnikov, AN
    Danilo, P
    Rosen, MR
    HEART RHYTHM, 2005, 2 (04) : 404 - 410
  • [47] The burden of atrial fibrillation in the Netherlands
    H. E. Heemstra
    R. Nieuwlaat
    M. Meijboom
    H. J. Crijns
    Netherlands Heart Journal, 2011, 19 : 373 - 378
  • [48] The burden of atrial fibrillation in the Netherlands
    Heemstra, H. E.
    Nieuwlaat, R.
    Meijboom, M.
    Crijns, H. J.
    NETHERLANDS HEART JOURNAL, 2011, 19 (09) : 373 - 378
  • [49] Hospital burden of atrial fibrillation
    Christiansen, C. Benn
    Lock-Hansen, M.
    Torp-Pedersen, C.
    EUROPEAN HEART JOURNAL, 2012, 33 : 379 - 379
  • [50] The Importance of Atrial Fibrillation Burden
    不详
    JOURNAL OF CARDIOVASCULAR NURSING, 2018, 33 (06) : 504 - 504